GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (MEX:CSL N) » Definitions » Tariff Resilience Score

CSL (MEX:CSL N) Tariff Resilience Score : 7/10 (As of Jun. 26, 2025)


View and export this data going back to 2019. Start your Free Trial

What is CSL Tariff Resilience Score?

CSL has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

CSL has CSL Ltd has a global presence with diversified manufacturing and sales. While it faces some tariff exposure, its strong market position and ability to adjust supply chains enhance resilience. The healthcare industry often benefits from tariff exemptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes CSL might have Highly Resilient.

Competitive Comparison of CSL's Tariff Resilience Score

For the Biotechnology subindustry, CSL's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSL's Tariff Resilience Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where CSL's Tariff Resilience Score falls into.


;
;

CSL  (MEX:CSL N) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

CSL Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of CSL's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (MEX:CSL N) » Definitions » Tariff Resilience Score
Comparable Companies
ASX:TLX ASX:MSB ASX:NEU ASX:CU6 ASX:PYC ASX:BOT ASX:CUV ASX:IMM ASX:DXB ASX:OCC VRTX REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT
Traded in Other Exchanges
CSLLY:USA CMXHF:USA CSJ:Germany CSJ:Germany CSJ:Germany CSL:Australia
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
Website
https://www.csl.com
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

CSL Headlines

No Headlines